Praxis Precision Medicines
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system disorders characterized by neuronal excitation-inhibition imbalance. The company offers cerebrum, a small molecule platform for CNS ...
Praxis Precision Medicines Logo
About Praxis Precision Medicines
Praxis Precision Medicines, Inc. operates as a clinical-stage genetic neuroscience company. The Company develops therapies for patients and families affected by complex and debilitating brain disorders. Praxis Precision Medicines serves patients in the United States.
Address
99 High Street, 30th Floor
Boston, 02110
United States
Year founded
2015
Number of employees
100-200
Report inaccurate data
Request an update to help us keep the brand up-to-date.
